Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024 sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 418,100 shares, a decrease of 7.7% from the January 15th total of 452,800 shares. Based on an average trading volume of 80,300 shares, […]
Purple Biotech (PPBT) Reaches Recommended Phase 2 Dose for NT219 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
REHOVOT, Israel, Feb. 01, 2024 Purple Biotech Ltd. , a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune.